167 related articles for article (PubMed ID: 7890768)
1. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.
Xu J; McKeehan K; Matsuzaki K; McKeehan WL
J Biol Chem; 1995 Mar; 270(11):6308-13. PubMed ID: 7890768
[TBL] [Abstract][Full Text] [Related]
2. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J
Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624
[TBL] [Abstract][Full Text] [Related]
3. Activin and inhibin binding to the soluble extracellular domain of activin receptor II.
Donaldson CJ; Vaughan JM; Corrigan AZ; Fischer WH; Vale WW
Endocrinology; 1999 Apr; 140(4):1760-6. PubMed ID: 10098513
[TBL] [Abstract][Full Text] [Related]
4. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor.
Matsuzaki K; Xu J; Wang F; McKeehan WL; Krummen L; Kan M
J Biol Chem; 1993 Jun; 268(17):12719-23. PubMed ID: 8389764
[TBL] [Abstract][Full Text] [Related]
5. Identification of a binding site on the type II activin receptor for activin and inhibin.
Gray PC; Greenwald J; Blount AL; Kunitake KS; Donaldson CJ; Choe S; Vale W
J Biol Chem; 2000 Feb; 275(5):3206-12. PubMed ID: 10652306
[TBL] [Abstract][Full Text] [Related]
6. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
Kleeff J; Ishiwata T; Friess H; Büchler MW; Korc M
Int J Cancer; 1998 Sep; 77(6):860-8. PubMed ID: 9714055
[TBL] [Abstract][Full Text] [Related]
7. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
[TBL] [Abstract][Full Text] [Related]
8. Formation and activation by phosphorylation of activin receptor complexes.
Willis SA; Zimmerman CM; Li LI; Mathews LS
Mol Endocrinol; 1996 Apr; 10(4):367-79. PubMed ID: 8721982
[TBL] [Abstract][Full Text] [Related]
9. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.
Lebrun JJ; Vale WW
Mol Cell Biol; 1997 Mar; 17(3):1682-91. PubMed ID: 9032295
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE).
Choi KC; Kang SK; Nathwani PS; Cheng KW; Auersperg N; Leung PC
Mol Cell Endocrinol; 2001 Mar; 174(1-2):99-110. PubMed ID: 11306176
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of vascular endothelial cell growth by activin-A.
McCarthy SA; Bicknell R
J Biol Chem; 1993 Nov; 268(31):23066-71. PubMed ID: 8226823
[TBL] [Abstract][Full Text] [Related]
12. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
13. Two distinct signaling pathways activated by activin A in glucose-responsive pancreatic beta-cell lines.
Shibata H; Kanzaki M; Takeuchi T; Miyazaki J; Kojima I
J Mol Endocrinol; 1996 Jun; 16(3):249-58. PubMed ID: 8782083
[TBL] [Abstract][Full Text] [Related]
14. Is the action of inhibin mediated via a unique receptor?
Robertson DM; Hertan R; Farnworth PG
Rev Reprod; 2000 Sep; 5(3):131-5. PubMed ID: 11006162
[TBL] [Abstract][Full Text] [Related]
15. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells.
Erämaa M; Hildén K; Tuuri T; Ritvos O
Endocrinology; 1995 Oct; 136(10):4382-9. PubMed ID: 7664658
[TBL] [Abstract][Full Text] [Related]
16. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.
Ebner R; Chen RH; Lawler S; Zioncheck T; Derynck R
Science; 1993 Nov; 262(5135):900-2. PubMed ID: 8235612
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
Takumi T; Moustakas A; Lin HY; Lodish HF
Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
[TBL] [Abstract][Full Text] [Related]
18. Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line.
Ying SY; Zhang Z
Breast Cancer Res Treat; 1996; 37(2):151-60. PubMed ID: 8750582
[TBL] [Abstract][Full Text] [Related]
19. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.
Coerver KA; Woodruff TK; Finegold MJ; Mather J; Bradley A; Matzuk MM
Mol Endocrinol; 1996 May; 10(5):534-43. PubMed ID: 8732684
[TBL] [Abstract][Full Text] [Related]
20. Activin A and activin receptors in the human thyroid: a link to the female predominance of goiter?
Schulte KM; Jonas C; Krebs R; Röher HD
Horm Metab Res; 2000 Oct; 32(10):390-400. PubMed ID: 11069203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]